Xiaolan Wang
Research Subjects
Xiaolan Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Denghui Zhu
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Junjun Wei
School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Meng Li
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Meng Yang
School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Shiqi Zhou
School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Weisheng Feng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, P. R. China
1 shared publication
Latest Publications
- Open Access
Neocornuside A–D, Four Novel Iridoid Glycosides from Fruits of Cornus officinalis and Their Antidiabetic Activity
Four previously undescribed iridoid glycosides neocornuside A–D (1–4), along with six known ones (5–10), were isolated from Cornus officinalis fruit. Their structures were elucidated by extensive spectroscopic (NMR, UV, IR, and MS) analysis and comparison with data reported in the literature. All isolates were assessed for their antidiabetic activity on the relative glucose consumption in insulin-induced insulin-resistant HepG2 cells. The results showed that compounds 1, 3, and 7 exhibited significant antidiabetic activities with EC50 values of 0.582, 1.275, and 0.742 μM, respectively. Moreover, compounds 1, 3, and 7 could improve the ability of 2-NBDG uptake of insulin-induced HepG2 cells.
Open AccessNeocornuside A–D, Four Novel Iridoid Glycosides from Fruits of Cornus officinalis and Their Antidiabetic Activity
Four previously undescribed iridoid glycosides neocornuside A–D (1–4), along with six known ones (5–10), were isolated from Cornus officinalis fruit. Their structures were elucidated by extensive spectroscopic (NMR, UV, IR, and MS) analysis and comparison with data reported in the literature. All isolates were assessed for their antidiabetic activity on the relative glucose consumption in insulin-induced insulin-resistant HepG2 cells. The results showed that compounds 1, 3, and 7 exhibited significant antidiabetic activities with EC50 values of 0.582, 1.275, and 0.742 μM, respectively. Moreover, compounds 1, 3, and 7 could improve the ability of 2-NBDG uptake of insulin-induced HepG2 cells.